An extract taken from green tea reduces cancer cells in the blood of patients with a form of leukaemia and may slow progression of the disease, a conference will hear.

Researchers at the prestigious Mayo Clinic in America have found that patients in the early stages of the most common form of leukaemia may respond well to taken supplements of a green tea extract.

The chemical, epigallocatechin galeate (EGCG), was found more than two thirds of 42 patients in the trial showed a significant reduction in the number of leukaemia cells in their blood or other signs the cancer was not spreading.

The findings, to be presented Monday at the annual meeting of the American Society of Clinical Oncology (ASCO).

 

Read article at: http://www.telegraph.co.uk